Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00674505Not ApplicableUnknown

Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis

Role: collaborator

NCT00453518Not ApplicableCompleted

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

Role: lead

NCT00349570Not ApplicableCompleted

Xtract™ Aspiration Catheter Registry Study

Role: lead

NCT00460187Not ApplicableCompleted

EPIC US Pivotal Study

Role: lead

NCT00346515Not ApplicableCompleted

EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Role: lead

NCT00309803Not ApplicableCompleted

EPIC European Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Role: lead

All 6 trials loaded